Pancreatic cancer cell lines as patient-derived avatars: genetic characterisation and functional utility | Gut
Hyaluronic acid fuels pancreatic cancer cell growth | eLife
Positive TLR4 expression is detected in six different pancreatic cancer... | Download Scientific Diagram
Molecules | Free Full-Text | A Novel Small Molecular Prostaglandin Receptor EP4 Antagonist, L001, Suppresses Pancreatic Cancer Metastasis
PAR-3 gene expression analysed by RT-PCR in six pancreatic cancer cell... | Download Scientific Diagram
Pancreatic cancer - Wikipedia
HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer - ScienceDirect
Vitamin D Receptor-Mediated Stromal Reprogramming Suppresses Pancreatitis and Enhances Pancreatic Cancer Therapy: Cell
Precision chemo-immunotherapy for pancreatic | EurekAlert!
Morphofunctional analysis of human pancreatic cancer cell lines in 2- and 3-dimensional cultures | Scientific Reports
Targeting Mitochondrial Complex I Overcomes Chemoresistance in High OXPHOS Pancreatic Cancer - ScienceDirect
Cancers | Free Full-Text | The Differential Clinical Impacts of Cachexia and Sarcopenia on the Prognosis of Advanced Pancreatic Cancer
Six1 increases pancreatic cancer cell proliferation in vitro and in... | Download Scientific Diagram
Frontiers | Risk Evaluation of EMT and Inflammation in Metastatic Pancreatic Cancer Cells Following Plasma Treatment
Cells | Free Full-Text | Preclinical Evaluation of 1,2-Diamino-4,5-Dibromobenzene in Genetically Engineered Mouse Models of Pancreatic Cancer
GSTM3 expression in six pancreatic cancer cell lines and PANC-1 and... | Download Scientific Diagram
PD-L1 is a direct target of cancer-FOXP3 in pancreatic ductal adenocarcinoma (PDAC), and combined immunotherapy with antibodies against PD-L1 and CCL5 is effective in the treatment of PDAC | Signal Transduction and
Cell surface expression of MICA/B on pancreatic cancer cell lines. Flow... | Download Scientific Diagram
Homogeneous antibody and CAR-T cells with improved effector functions targeting SSEA-4 glycan on pancreatic cancer | PNAS
Mutant p53 drives invasiveness and metastasis of pancreatic cancer... | Download Scientific Diagram
Frontiers | Stroma Involvement in Pancreatic Ductal Adenocarcinoma: An Overview Focusing on Extracellular Matrix Proteins
Dynamic profiling of immune microenvironment during pancreatic cancer development suggests early intervention and combination strategy of immunotherapy - eBioMedicine
Pancreatic cancer cell lines as patient-derived avatars: genetic characterisation and functional utility | Gut
Therapeutic challenges and current immunomodulatory strategies in targeting the immunosuppressive pancreatic tumor microenvironment | Journal of Experimental & Clinical Cancer Research | Full Text
Reprogramming pancreatic stellate cells via p53 activation: A putative target for pancreatic cancer therapy | PLOS ONE
